UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estrogen as a key regulator of energy homeostasis and metabolic health

Biomedicine & pharmacotherapy, 2022-12, Vol.156, p.113808-113808, Article 113808

2022

Volltextzugriff (PDF)

Involvement of Urokinase-Type Plasminogen Activator System in Cancer: An Overview

Medicinal research reviews, 2014-09, Vol.34 (5), p.918-956

2014

Volltextzugriff (PDF)

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

Cancer and metastasis reviews, 2012-06, Vol.31 (1-2), p.143-162

2012

Volltextzugriff (PDF)

Gene of the month: Interleukin 6 (IL-6)

Journal of clinical pathology, 2014-11, Vol.67 (11), p.932-937

2014

Volltextzugriff (PDF)

Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model

PloS one, 2011-09, Vol.6 (9), p.e24405

2011

Volltextzugriff (PDF)

Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer

Cytokine & growth factor reviews, 2013-04, Vol.24 (2), p.163-173

2013

Volltextzugriff (PDF)

Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies

PloS one, 2013-04, Vol.8 (4), p.e60817

2013

Volltextzugriff (PDF)

p70 Ribosomal protein S6 kinase (Rps6kb1): an update

Journal of clinical pathology, 2014-12, Vol.67 (12), p.1019-1025

2014

Volltextzugriff (PDF)

Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model

Journal of nanobiotechnology, 2015-03, Vol.13 (1), p.25-25, Article 25

2015

Volltextzugriff (PDF)

Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma

American journal of clinical oncology, 2015-08, Vol.38 (4), p.388-394

2015

Volltextzugriff (PDF)

Potent Inhibition of Tubulin Polymerisation and Proliferation of Paclitaxel-resistant 1A9PTX22 Human Ovarian Cancer Cells by Albendazole

Anticancer research, 2009-10, Vol.29 (10), p.3791-3796

2009

Volltextzugriff (PDF)

Retraction: Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer

Molecular cancer research, 2024-04, Vol.22 (4), p.415-415

2024

Volltextzugriff (PDF)

Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole

BMC cancer, 2010-04, Vol.10 (1), p.143-143, Article 143

2010

Volltextzugriff (PDF)

Inhibition of Hepatocellular Cancer by EB1089: In Vitro and In Vivo Study

Anticancer research, 2008-11, Vol.28 (6A), p.3757-3761

2008

Volltextzugriff (PDF)

The role of ERα36 in cell type-specific functions of estrogen and cancer development

Pharmacological research, 2021-01, Vol.163, p.105307-105307, Article 105307

2021

Volltextzugriff (PDF)

Albendazole-Cyclodextrin Complex: Enhanced Cytotoxicity in Ovarian Cancer Cells

Anticancer research, 2008-09, Vol.28 (5A), p.2775-2779

2008

Volltextzugriff (PDF)

Effect of Cross-Linking on the Performance of Micelles As Drug Delivery Carriers: A Cell Uptake Study

Biomacromolecules, 2012-03, Vol.13 (3), p.814-825

2012

Volltextzugriff (PDF)

MUC1 as a potential target in anticancer therapies

American journal of clinical oncology, 2015-02, Vol.38 (1), p.108-118

2015

Volltextzugriff (PDF)

Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer

Molecular cancer research, 2013-10, Vol.11 (10), p.1279-1291

2013

Volltextzugriff (PDF)

Diffuse malignant peritoneal mesothelioma – An update on treatment

Cancer treatment reviews, 2012-10, Vol.38 (6), p.605-612

2012

Volltextzugriff (PDF)

MUC1 has Prognostic Significance in Malignant Peritoneal Mesothelioma

The International journal of biological markers, 2013-07, Vol.28 (3), p.303-312

2013

Volltextzugriff (PDF)

HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor

Journal of Oncology, 2012-01, Vol.2012 (2012), p.1-9

2012

Volltextzugriff (PDF)

Minocycline inhibits growth of epithelial ovarian cancer

Gynecologic oncology, 2012-05, Vol.125 (2), p.433-440

2012

Volltextzugriff (PDF)

Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics

Pituitary, 2020-06, Vol.23 (3), p.232-245

2020

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(80)

Sprache

Englisch
(80)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Estrogen as a key regulator of energy homeostasis and metabolic health

Involvement of Urokinase-Type Plasminogen Activator System in Cancer: An Overview

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

Gene of the month: Interleukin 6 (IL-6)

Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model

Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer

Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies

p70 Ribosomal protein S6 kinase (Rps6kb1): an update

Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model

Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma

Potent Inhibition of Tubulin Polymerisation and Proliferation of Paclitaxel-resistant 1A9PTX22 Human Ovarian Cancer Cells by Albendazole

Retraction: Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer

Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole

Inhibition of Hepatocellular Cancer by EB1089: In Vitro and In Vivo Study

The role of ERα36 in cell type-specific functions of estrogen and cancer development

Albendazole-Cyclodextrin Complex: Enhanced Cytotoxicity in Ovarian Cancer Cells

Effect of Cross-Linking on the Performance of Micelles As Drug Delivery Carriers: A Cell Uptake Study

MUC1 as a potential target in anticancer therapies

Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer

Diffuse malignant peritoneal mesothelioma – An update on treatment

MUC1 has Prognostic Significance in Malignant Peritoneal Mesothelioma

HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

Minocycline inhibits growth of epithelial ovarian cancer

Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics

Suchergebnisse filtern